Cytokine and radical inhibition in septic intestinal barrier failure

Journal of Surgical Research

Volumn 193, Issue 2, 2015, Pages 831-840

  Schulz, Konrad ^a   Sommer, Olaf ^a   Jargon, Dirk ^a   Utzolino, Stefan ^a   Clement, Hans Willi ^a   Strate, Tim ^b   Von Dobschuetz, Ernst ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Krankenhaus Reinbek St Adolf Stift   (Germany)

Author keywords

Colon; Gut; LPS; Permeability; Pyruvate; Rat; Sepsis; Small intestine; Tempol; VIP

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PARECOXIB; PYRUVIC ACID; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TEMPOL; VASOACTIVE INTESTINAL POLYPEPTIDE; AMINE OXIDE; CYCLOOXYGENASE 2 INHIBITOR; ISOXAZOLE DERIVATIVE; SCAVENGER; SPIN LABELING;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; COLON; CONTROLLED STUDY; ENZYME ACTIVITY; EX VIVO STUDY; INTESTINE MUCOSA PERMEABILITY; MALE; NEUTROPHIL; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; SMALL INTESTINE; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD; COMPLICATION; DRUG EFFECTS; DRUG SCREENING; ENZYMOLOGY; INTESTINE MUCOSA; METABOLISM; MULTIPLE ORGAN FAILURE; PERMEABILITY; SEPSIS; SPIN LABELING; SPRAGUE DAWLEY RAT;

ANIMALS; CYCLIC N-OXIDES; CYCLOOXYGENASE 2 INHIBITORS; DRUG EVALUATION, PRECLINICAL; FREE RADICAL SCAVENGERS; INTERLEUKIN-6; INTESTINAL MUCOSA; ISOXAZOLES; LIPOPOLYSACCHARIDES; MALE; MULTIPLE ORGAN FAILURE; NADPH OXIDASE; NEUTROPHILS; PERMEABILITY; PYRUVIC ACID; RATS, SPRAGUE-DAWLEY; SEPSIS; SPIN LABELS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84916900280     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2014.08.056     Document Type: Article

References (57)

1. J.D. Johnston, C.J. Harvey, I.S. Menzies, and D.F. Treacher Gastrointestinal permeability and absorptive capacity in sepsis Crit Care Med 24 1996 1144
2. J. MacFie, B.S. Reddy, M. Gatt, P.K. Jain, R. Sowdi, and C.J. Mitchell Bacterial translocation studied in 927 patients over 13 years Br J Surg 93 2006 87
3. H.C. Pape, A. Dwenger, and G. Regel Increased gut permeability after multiple trauma Br J Surg 81 1994 850
4. C.M. Ryan, S.H. Bailey, E.A. Carter, D.A. Schoenfeld, and R.G. Tompkins Additive effects of thermal injury and infection on gut permeability Arch Surg 129 1994 325
5. B.J. Ammori, P.C. Leeder, and R.F. King Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality J Gastrointest Surg 3 1999 252
6. S. Fritz, T. Hackert, and W. Hartwig Bacterial translocation and infected pancreatic necrosis in acute necrotizing pancreatitis derives from small bowel rather than from colon Am J Surg 200 2010 111
7. L. Barthe, J.F. Woodley, S. Kenworthy, and G. Houin An improved everted gut sac as a simple and accurate technique to measure paracellular transport across the small intestine Eur J Drug Metab Pharmacokinet 23 1998 313
8. C. Hierholzer, B. Harbrecht, and J.M. Menezes Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock J Exp Med 187 1998 917
9. G. Kolios, V. Valatas, and S.G. Ward Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle Immunology 113 2004 427
10. Y.J. Lee, I.J. Kang, R. Bunger, and Y.H. Kang Enhanced survival effect of pyruvate correlates MAPK and NF-kappaB activation in hydrogen peroxide-treated human endothelial cells J Appl Physiol 96 2004 793
11. R. Venkataraman, J.A. Kellum, M. Song, and M.P. Fink Resuscitation with Ringer's ethyl pyruvate solution prolongs survival and modulates plasma cytokine and nitrite/nitrate concentrations in a rat model of lipopolysaccharide-induced shock Shock 18 2002 507
12. W.J. Liaw, T.H. Chen, and Z.Z. Lai Effects of a membrane-permeable radical scavenger, Tempol, on intraperitoneal sepsis-induced organ injury in rats Shock 23 2005 88
13. S.R. Zamuner, N. Warrier, A.G. Buret, W.K. MacNaughton, and J.L. Wallace Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction Gut 52 2003 1714
14. J. Osterberg, M. Ljungdahl, and U. Haglund Influence of cyclooxygenase inhibitors on gut immune cell distribution and apoptosis rate in experimental sepsis Shock 25 2006 147
15. A.J. Harmar, J. Fahrenkrug, and I. Gozes Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1 Br J Pharmacol 166 2012 4
16. H. Ibrahim, P. Barrow, and N. Foster VIP as a potential therapeutic agent in gram negative sepsis Endocr Metab Immune Disord Drug Targets 12 2012 308
17. C. Martinez, Y. Juarranz, and C. Abad Analysis of the role of the PAC1 receptor in neutrophil recruitment, acute-phase response, and nitric oxide production in septic shock J Leukoc Biol 77 2005 729
18. K. Effenberger-Neidnicht, L. Brencher, M. Broecker-Preuss, T. Hamburger, F. Petrat, and G.H. de Immune stimulation by exogenous melatonin during experimental endotoxemia Inflammation 37 2014 738
19. M.P. Fink, and S.O. Heard Laboratory models of sepsis and septic shock J Surg Res 49 1990 186
20. S.J. Parker, and P.E. Watkins Experimental models of gram-negative sepsis Br J Surg 88 2001 22
21. Q. Wang, H.M. van, and X.N. Tang Pyruvate protects against experimental stroke via an anti-inflammatory mechanism Neurobiol Dis 36 2009 223
22. J.S. Yi, T.Y. Kim, K.D. Kyu, and J.Y. Koh Systemic pyruvate administration markedly reduces infarcts and motor deficits in rat models of transient and permanent focal cerebral ischemia Neurobiol Dis 26 2007 94
23. L. Cicalese, K. Lee, W. Schraut, S. Watkins, A. Borle, and R. Stanko Pyruvate prevents ischemia-reperfusion mucosal injury of rat small intestine Am J Surg 171 1996 97
24. H. Berisha, H. Foda, H. Sakakibara, M. Trotz, H. Pakbaz, and S.I. Said Vasoactive intestinal peptide prevents lung injury due to xanthine/xanthine oxidase Am J Physiol 259 2 Pt 1 1990 L151
25. S.S. Padi, N.K. Jain, S. Singh, and S.K. Kulkarni Pharmacological profile of parecoxib: a novel, potent injectable selective cyclooxygenase-2 inhibitor Eur J Pharmacol 491 2004 69
26. S.S. Short, J. Wang, and S.L. Castle Low doses of celecoxib attenuate gut barrier failure during experimental peritonitis Lab Invest 93 2013 1265
27. S. Cuzzocrea, M.C. McDonald, and E. Mazzon Beneficial effects of tempol, a membrane-permeable radical scavenger, on the multiple organ failure induced by zymosan in the rat Crit Care Med 29 2001 102
28. B. Elmedal, M.Y. de Dam, M.J. Mulvany, and U. Simonsen The superoxide dismutase mimetic, tempol, blunts right ventricular hypertrophy in chronic hypoxic rats Br J Pharmacol 141 2004 105
29. I. Frolkis, Y. Klein, and C. Locker Vipera aspis venom reduces lethality and down-regulates tumor necrosis factor-alpha in a rat model of LPS-induced sepsis Cytokine 49 2010 319
30. I. Minkenberg, and E. Ferber Lucigenin-dependent chemiluminescence as a new assay for NAD(P)H-oxidase activity in particulate fractions of human polymorphonuclear leukocytes J Immunol Methods 71 1984 61
31. A. Field Discovering statistics using SPSS 2009 Sage Publications London
32. P.V. Balimane, S. Chong, and R.A. Morrison Current methodologies used for evaluation of intestinal permeability and absorption J Pharmacol Toxicol Methods 44 2000 301
33. C.A. Santos, J.S. Jacob, and B.A. Hertzog Correlation of two bioadhesion assays: the everted sac technique and the CAHN microbalance J Control Release 61 1999 113
34. T.H. Wilson, and G. Wiseman The use of sacs of everted small intestine for the study of the transference of substances from the mucosal to the serosal surface J Physiol 123 1954 116
35. G.A. Nieuwenhuijzen, and R.J. Goris The gut: the 'motor' of multiple organ dysfunction syndrome? Curr Opin Clin Nutr Metab Care 2 1999 399
36. B.M. Babior, R.S. Kipnes, and J.T. Curnutte Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent J Clin Invest 52 1973 741
37. M.P. Fink Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness Curr Opin Crit Care 9 2003 143
38. R.C. Bone Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation Crit Care Med 24 1996 163
39. J.R. Border Hypothesis: sepsis, multiple systems organ failure, and the macrophage Arch Surg 123 1988 285
40. C. Yue, B. Ma, Y. Zhao, Q. Li, and J. Li Lipopolysaccharide-induced bacterial translocation is intestine site-specific and associates with intestinal mucosal inflammation Inflammation 35 2012 1880
41. D.W. Powell Barrier function of epithelia Am J Physiol 241 1981 G275
42. J. Grootjans, G. Thuijls, F. Verdam, J.P. Derikx, K. Lenaerts, and W.A. Buurman Non-invasive assessment of barrier integrity and function of the human gut World J Gastrointest Surg 2 2010 61
43. E. Damiani, B. Kalinska, and A. Canapa The effects of nitroxide radicals on oxidative DNA damage Free Radic Biol Med 28 2000 1257
44. Y.Y. Koh, W.K. Jeon, and Y.K. Cho The effect of intestinal permeability and endotoxemia on the prognosis of acute pancreatitis Gut Liver 6 2012 505
45. J. Vasquez-Vivar, A. Denicola, R. Radi, and O. Augusto Peroxynitrite-mediated decarboxylation of pyruvate to both carbon dioxide and carbon dioxide radical anion Chem Res Toxicol 10 1997 786
46. E. Bassenge, O. Sommer, M. Schwemmer, and R. Bunger Antioxidant pyruvate inhibits cardiac formation of reactive oxygen species through changes in redox state Am J Physiol Heart Circ Physiol 279 2000 H2431
47. T. Hamburger, M. Broecker-Preuss, M. Hartmann, F.U. Schade, G.H. de, and F. Petrat Effects of glycine, pyruvate, resveratrol, and nitrite on tissue injury and cytokine response in endotoxemic rats J Surg Res 183 2013 e7
48. C.A. Sims, S. Wattanasirichaigoon, M.J. Menconi, A.M. Ajami, and M.P. Fink Ringer's ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats Crit Care Med 29 2001 1513
49. W.M. Nauseef Biological roles for the NOX family NADPH oxidases J Biol Chem 283 2008 16961
50. E. Onur, B. Akalin, and K. Memisoglu Ethyl pyruvate improves healing of colonic anastomosis in a rat model of peritonitis Surg Innov 19 2012 394
51. M. Delgado, D. Pozo, and D. Ganea The significance of vasoactive intestinal peptide in immunomodulation Pharmacol Rev 56 2004 249
52. M. Delgado, and D. Ganea Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivo J Immunol 167 2001 966
53. R. Yang, X. Han, and T. Uchiyama IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice Am J Physiol Gastrointest Liver Physiol 285 2003 G621
54. S. Cuzzocrea, S.G. de, and G. Costantino IL-6 knock-out mice exhibit resistance to splanchnic artery occlusion shock J Leukoc Biol 66 1999 471
55. S. Cuzzocrea, S.G. de, and G. Costantino Role of interleukin-6 in a non-septic shock model induced by zymosan Eur Cytokine Netw 10 1999 191
56. Q. Wang, C.H. Fang, and P.O. Hasselgren Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice Am J Physiol Regul Integr Comp Physiol 281 2001 R1013
57. R. Atreya, J. Mudter, and S. Finotto Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo Nat Med 6 2000 583